Are You or Someone You Know Living with Alzheimer’s Disease?
Athira Pharma is Conducting Clinical Trials of fosgonimeton
Open Label Extension Study for Participants Who Completed the LIFT-AD or ACT-AD Trial
“ATH-1017 is a fast acting, novel approach that may have long lasting results”.